{"cdcTestId":"2013-0440","testcaseName":"#2 with interval of 4 weeks from #1","vaccineGroup":"HPV","evaluationTestType":"Interval: At Minimum","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2011-09-21T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2023-02-21T00:00:00","recommendedDate":"2023-03-21T00:00:00","pastDueDate":"2023-11-17T00:00:00"},"doses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"HPV9","cvx":"165","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-15T08:43:55.541","generalDescription":"This test case describes when a second dose is administered at an interval of 4 weeks -4 days but before 5 months that a repeat dose or third dose should be forecasted.","changedInVersion":"3.2","reasonForChange":"Updated to reflect ACIP recommendations for the HPV 2 dose series."}